Cipro generics approved
Executive Summary
Dr. Reddy's will take its generic ciprofloxacin to market with 180 days of exclusivity for a 100 mg tablet. Pediatric exclusivity for Bayer's Cipro expired June 9, prompting FDA approval of 13 ciprofloxacin ANDAs by various manufacturers. Dr. Reddy's generic is the only 100 mg dose approved; the other ANDAs cover 250 mg, 500 mg and 750 mg dosage strengths. Barr, which is one of the 13 ANDAs approved, has been marketing an "authorized" generic version of ciprofloxacin (250 mg, 500 mg, 750 mg) since June 2003 (1"The Pink Sheet" June 16, 2003, In Brief). Concerns about potential terrorist attacks involving anthrax prompted debate in 2001 over whether HHS should override Bayer's patent exclusivity to allow generics to come to market (2"The Pink Sheet" Oct. 22, 2001, p. 11)...
You may also be interested in...
Bayer May Cut U.S. Sales Force After Cipro Generics Enter Market
Bayer is looking to make further cuts in its U.S. pharmaceutical division following entry of Cipro generics, Bayer Health Care Chairman Arthur Higgins said during an earnings conference Aug. 3
Barr Cipro authorized generic
Barr launches authorized generic of Bayer's Cipro under patent settlement. The ciprofloxacin patent expires Dec. 9, 2003, and Bayer is seeking pediatric exclusivity. Firms are negotiating an agreement that could allow Barr to distribute ciprofloxacin during exclusivity period...
HHS Expects To Push Cipro Price To Generics Level Thru Bayer Negotiations
HHS is negotiating with Bayer over the price of Cipro (ciprofloxacin) as part of the federal stockpiling of the antibiotic.